Congratulations to Jeremy Simonetto (Year 8, St Patricks College) for being runner up in the 2020 UNSW Bragg Student Prize for Science Writing.
Year 8 student at St Patricks College, Jeremy Simonetto, discusses the potential planet-changing uses for iPS cells in medical research in his entry, awarded runner-up in the UNSW Bragg Student Prize for Science Writing, under the 2020 theme The Big Ideas Saving the Planet.
Well-structured, with a coherent narrative, Jeremy offers a useful fly-through of the potential and pitfalls of stem cell research, stresses one of the 2020 judges, science writer and editor Sara Phillips.
Read Jeremys full essay below.
RELATED: How one school is using the Bragg science writing prize to challenge gifted students
Imagine a future where genetic diseases are a thing of the past. Where conditions like leukemia can be cured in one treatment, and tissue grafts can be made bespoke to-order. A future that could be possible with the advent of induced pluripotent stem cells (or iPS cells for short), which have the potential to revolutionise in the field of medicine.
Induced pluripotent stem cells are skin or blood cells that have been genetically reprogrammed to become stem cells in other words, cells that can become any other bodily cell. Through inserting genes into the initial skin or blood cells, they begin a 23 week-long process in which the cell slowly converts back into a pluripotent state a stem cell. From there, these cells are converted into embryoids, structures similar to early embryos. Then, after a few weeks, they are diverted to become particular cells, such as muscle or brain cells.
The introduction of iPS cells can provide a solution to an important ethical problem. Scientists are now starting to use iPS cells to make organoids or miniature versions of organs. These organoids can then be used as model environments for the testing of new medicines. But, what does this have to do with ethics? Well, theres hope that these organoids can provide an alternative to animal testing, a cruel method of trialling drugs to ensure they are safe for use in humans. Additionally, testing on organoids is more accurate than on animals, as animals sometimes respond differently to humans, an instrumental factor in determining if a drug is okay for use by people.
These iPS cell-derived organoids also have another use, which is currently under development. They can be used to model diseases in lab conditions, tracking the exact causes, spread and behaviour of sicknesses ranging from the common cold to malignant cancer. It works through creating a miniature copy of an organ before exposing it to a disease. From there, scientists watch the progression of the disease from its earliest stages up until its critical mass, studying how the body reacts. And this information can have amazing results. It can help researchers gain a better insight into the immune system and see how it responds to threats. It also helps to see what causes cancers to form and spread, to find ways to prevent and stop this from happening. Even now, scientists are modelling COVID-19 on organoids, to see why certain people have different reactions to the virus, why and how it infects and spreads around the body, and understand why it causes long-lasting damage to patients even after theyve recovered.
Thats not all, however. iPS cells also help scientists to understand genetic diseases and how they are caused. By studying organoids, scientists can see when the earliest traces of genetic conditions emerge in a persons cells. For many of these diseases, which start to appear during foetal development, such as haemophilia, cystic fibrosis, Tay-Sachs disease, and muscular dystrophy, it could provide an insight into how they come about. With further research, it could even lead to ways of preventing these diseases in the womb before they even develop. A true medical ethos prevention better than cure.
Even with something as significant as this, weve only scratched the surface. There is hope that iPS cells themselves could provide the pathway to treating many serious illnesses. This can be done through transplants that do not rely on the patients acceptance or rejection of new cells because they are derived from their own. An example of this is in bone marrow diseases, such as leukemia. By making healthy bone marrow cells from already-existing skin cells, they can then be transplanted to replace the cancerous cells without the need for anti-rejection drugs. This is critical because many of these drugs involve strong immune suppression, which drastically weakens a persons immune response, and has to be taken for the rest of their life. Additionally, in patients who cant take anti-rejection drugs (for example, as a result of medical complications or health conditions) it will increase the transplants rate of success because it does not rely on the risky chance of acceptance. The same principle with bone marrow diseases can be applied to treat a myriad of other conditions, from cirrhosis to Type 1 diabetes.
RELATED: Bragg judges reveal their top 3 writing tips
But, while all these potential advancements are within our grasp, how could this change the future for our planet? Well, when you look at it, the possibilities of iPS cells are endless. The diseases mentioned above are just a few of the thousands that iPS cells could help to treat. It could revolutionise medicine, taking conditions we now think of as fatal and providing cures, potentially saving millions of lives. Even making certain diseases extinct forever. iPS cells, the stem of the future.
For the2020 UNSW Bragg Student Prize for Science Writing we asked Australian high school students to enter 800-word essays responding to the 2020 theme of saving the planet, identifying and discussing a problem in the world that has yet to be solved by contemporary science and technology.
This article was written by a STEM Contributor for Careers with STEM. To learn more, please visit our contact page.
Read more here:
iPS Cells: The STEM of the Future - Careers with STEM
- Panasonic and Shinobi Therapeutics Partner to Develop Efficient and Cost-Effective iPS Cell Therapy Manufacturing ... - PR Newswire - April 24th, 2024
- SCG CELL THERAPY AND A*STAR LAUNCH JOINT LABS WITH COLLABORATION NEARING S$30 MILLION TO ... - PR Newswire - April 20th, 2024
- Detection of biomagnetic signals from induced pluripotent stem cell-derived cardiomyocytes using deep learning with ... - Nature.com - April 1st, 2024
- Researchers discover new microRNA-regulated pathway to boost iPS cell-derived platelet production - Phys.org - March 30th, 2024
- Standardized production of hPSC-derived cardiomyocyte aggregates in stirred spinner flasks - Nature.com - March 28th, 2024
- Synthetic Circuits Reveal the Key to Rewinding the Cellular Clock - The Scientist - March 13th, 2024
- synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy - Nature.com - March 3rd, 2024
- Breaking through new research barriers with iPSC technology - News-Medical.Net - February 15th, 2024
- Abu Dhabi Stem Cells Centre partners with Rege Nephro and Kyoto University's Center for iPS Cell Research and ... - Abu Dhabi Media Office - January 12th, 2024
- Abu Dhabi Stem Cells Center partners with Japan-based Kyoto University and Rege Nephro - ZAWYA - January 12th, 2024
- Efficient and reproducible generation of human induced pluripotent stem cell-derived expandable liver organoids for ... - Nature.com - December 23rd, 2023
- Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming - Nature.com - December 15th, 2023
- Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform - PR Newswire - December 13th, 2023
- CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes ... - Nature.com - December 7th, 2023
- World Hindu Congress 2023: Know all about the sessions and speakers - Organiser - November 23rd, 2023
- VCCT Inc., Leading the Field of Retinal Regeneration through iPS ... - Business Wire - November 21st, 2023
- Efficient protocol for the differentiation of kidney podocytes from ... - Nature.com - November 17th, 2023
- Vitamin B12 is a limiting factor for induced cellular plasticity and ... - Nature.com - November 17th, 2023
- Study reveals the critical role of microglia in human brain development - Medical Xpress - November 15th, 2023
- VCCT Inc., Leading the Field of Retinal Regeneration through iPS Cells, Raises 600 million Japanese yen (approximately $4 million USD) through... - November 15th, 2023
- Who are the leading innovators in iPSCs for the pharmaceutical ... - Pharmaceutical Technology - November 7th, 2023
- Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous... - November 5th, 2023
- Systematic differences in discovery of genetic effects on gene ... - Nature.com - October 21st, 2023
- Pairwise biosynthesis of ion channels stabilizes excitability and ... - pnas.org - October 11th, 2023
- Scientists find multitude of genes associated with autism - The Statesman - October 9th, 2023
- Stem Cell Banking Market is Expected to Reach USD 16,474.30 ... - Digital Journal - October 7th, 2023
- Probing the individuality of cells and molecules - Open Access Government - October 5th, 2023
- Thymmune Therapeutics Receives $37M in Funding from the ... - Manchestertimes - October 3rd, 2023
- Thymmune Therapeutics Receives $37M in Funding from the ... - Business Wire - September 29th, 2023
- Less Funding to More Researchers Gets Nobel-level Results, Study ... - The Japan News - September 27th, 2023
- Brentuximab Vedotin Plus AVD Gets Positive CHMP Opinion for ... - OncLive - September 20th, 2023
- DKMS BMST Foundation India and Kokilaben Hospital unite to spread awareness about the Importance of Stem Cell Donation on World Marrow Donor Day - APN... - September 18th, 2023
- Vitamin B6 is governed by the local compartmentalization of ... - Science - September 14th, 2023
- Dolly the sheep creator Ian Wilmut dies aged 79 - BBC - September 14th, 2023
- Scientist who created Dolly the sheep dies aged 79: Professor Sir Ian Wilmut passes away five years after reve - Daily Mail - September 11th, 2023
- The global kits market is expected to grow at a CAGR of 7.4% from ... - Digital Journal - September 8th, 2023
- Eterna Therapeutics Announces Initiation of Development Activities ... - PipelineReview.com - September 8th, 2023
- Tokyo: 100 Years of Urban Regeneration / Tokyo's Nihonbashi Area ... - The Japan News - August 31st, 2023
- Transcriptome-based prediction of drugs, inhibiting ... - Nature.com - August 30th, 2023
- From the birds and the bees to IVG - The Gauntlet - August 26th, 2023
- Breakthrough creates stem cells without any memories - Freethink - August 26th, 2023
- Aging impairs the neurovascular interface in the heart - Science - August 26th, 2023
- For This Venture Capitalist, Research on Aging Is Personal; 'Bob ... - The Wall Street Journal - August 22nd, 2023
- Unleashing Potential: Illuminating the Future of Healthcare through Revolutionary Induced Pluripotent Stem Cel - openPR - August 18th, 2023
- A 'memory wipe' for stem cells may be the key to better therapies - The Conversation - August 16th, 2023
- Erasing epigenetic 'memory' to improve the quality of stem cells - FierceBiotech - August 16th, 2023
- HebeCell and Logomix Announce Collaboration for the ... - Business Wire - August 16th, 2023
- HebeCell and Logomix Announce Collaboration for the ... - Valdosta Daily Times - August 11th, 2023
- Advancing Clinical Trials with iPSC-Derived Liver Organoids - Microbioz India - August 11th, 2023
- Activation of cAMP (EPAC2) signaling pathway promotes hepatocyte ... - Nature.com - August 1st, 2023
- IPS HEART Announces Peer-Reviewed Publication in Cells of Aging Damage Reversal Showing GIVI-MPC Stem Cell Therapys Ability to Create New Skeletal... - July 30th, 2023
- Femtech in Japan: An Industry on the Rise - Femtech Insider - July 28th, 2023
- Association between enhanced carbonyl stress and decreased ... - Nature.com - July 28th, 2023
- Defects in early synaptic formation and neuronal function in Prader ... - Nature.com - July 27th, 2023
- IPS HEART Announces Peer-Reviewed Publication in Cells of ... - Business Wire - July 25th, 2023
- Cure to Autism and Alzheimer's May Be in Space, Says 1st Brazilian Scientist who Will Be on The ISS - Folha de S.Paulo - July 25th, 2023
- Futurama's Resurrection Ruins The Perfect Ending (& Shows Must ... - Looper - July 25th, 2023
- University Of Massachusetts Amherst's Team Bags Honour Of 2023 Armstrong Fund For Science Award - India Education Diary - July 20th, 2023
- Scientists working on IVG, a new reproductive method that can make human babies in labs - IndiaTimes - July 19th, 2023
- Co-transplantation of autologous Treg cells in a cell therapy for ... - Nature.com - July 13th, 2023
- Magic Valley and Biocellion Join Forces to Improve Bioreactor Tech ... - vegconomist - the vegan business magazine - July 13th, 2023
- IPS HEART Receives U.S. FDA Rare Pediatric Drug Designation for ... - Tullahoma News and Guardian - July 10th, 2023
- Hitachi : forms strategic research collaboration with Mass General Brigham in the field of regenerative medicine and GCT - Marketscreener.com - July 6th, 2023
- Cell therapy limitations with iPS-based multi-cell therapeutics - Drug Target Review - July 6th, 2023
- Remembering Dolly- The Clone Sheep On Her Birth Anniversary - Free Press Journal - July 4th, 2023
- Labs and Translational Research - UMass Medical School - June 28th, 2023
- Cellusion raises 2.83B series C round to progress iPS cell-derived ... - BioWorld Online - June 14th, 2023
- Japan-based Fujifilm introduces first-of-its-kind human iPSC-derived ... - BSA bureau - June 6th, 2023
- ALS: Parkinson's drug ropinirole may be an effective treatment - Medical News Today - June 4th, 2023
- Scientists predict lab-grown babies in five years - Kidspot - June 4th, 2023
- Lab-grown babies could become a reality within five years - Earth.com - May 26th, 2023
- Leading healthcare experts from MENA and beyond to explore the future of precision medicine in the region at PMES 23 this month - ZAWYA - May 24th, 2023
- Long-Awaited Ax-2 Mission Launches, Heads to Space Station - AmericaSpace - May 22nd, 2023
- Eterna Therapeutics and Factor Bioscience Announce New Data on ... - GlobeNewswire - May 17th, 2023
- Research Assistant job with UNITED ARAB EMIRATES ... - Times Higher Education - May 10th, 2023
- Regulation of synaptic connectivity in schizophrenia spectrum by ... - Nature.com - April 29th, 2023
- Researchers Discover Key Role of Glucose in Brain Activity - Laboratory Equipment - April 25th, 2023
- Structure of Huntington's Protein Revealed - Technology Networks - April 21st, 2023
- Study of brain immune cell infection may explain long COVID ... - NHK WORLD - April 19th, 2023
- The Mechanism That Regulates Activity of Memory Gene - Neuroscience News - April 19th, 2023
Recent Comments